Article
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
18 Feb 2020
Abstract excerpt
Many cytokines are crucial drivers of cancers and autoimmune conditions. These proteins bind to receptors and signal their responses through Janus kinase (JAK) and signal transducer and activator of transcription (STAT) pathways. Genetic variations in the JAK-STAT pathway are correlated with the increased risk of cancers, autoimmunity as well as inflammatory diseases. Targeting JAKs and STATs can be a safe and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
